Loading data...
Edgewater Corporation
CEO
Masahiko Fukuzawa
N/A
Recent News & PR
Summary
Message to Participants
Detailed Information
Edgewater Corporation utilizes big data related to immunity and genetics, leveraging AI technology to provide services that contribute to the health and medical fields. We aim to analyze real-world data for pharmaceutical companies and medical institutions to solve challenges.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
AI / Data Analytics, Healthcare / Biotech, Enterprise DX / Business Transformation
本社所在地
5-3-10 Seijo, Setagaya-ku, Tokyo, Japan
設立日
2015年1月15日
資本金
3,247万円
Employee Count
3
Industry Outlook & Trends for Edgewater Corporation
Driven by aging populations and rising healthcare costs, the healthcare and biotech market where Edgewater Corporation operates is growing globally. Telemedicine, digital health via wearables, AI-driven drug discovery, and gene therapy are advancing rapidly. The industry is shifting from treatment to prevention, increasing demand for highly personalized health solutions like those developed by Edgewater Corporation.
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.